Nestle has launched a new protein shot designed to aid weight loss by helping manage hunger and naturally boost GLP-1 hormone levels. Meanwhile, the FDA has declared the shortage of tirzepatide, the active ingredient in Eli Lilly’s Zepbound, over, impacting the weight-loss drug market. The rise in popularity of medications like Wegovy and Zepbound is also leading to increased healthcare utilization in the U.S., with more patients being diagnosed and prescribed for various conditions.
